1st Quarter - Report

AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$182,592
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

HR1 - American Recovery and Reinvestment Act of 2009 Sections on Health Information Technology

LobbyistCovered position, as disclosed
MARCIE BOUGH Former Legislative Assistant in Senate
HARRY HAGEL —
KRISTINA E LUNNER —

Contacted: Food & Drug Administration (FDA); White House Office; Internal Revenue Service (IRS); Environmental Protection Agency (EPA); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1 (111th)

Health Issues HCR

HR756 - National Pain Care Policy Act of 2009 HR1259 - The Dextromethorphan Distribution Act of 2009 HR179 - Community AIDS and Hepatitis Prevention Act (Docket Number: IRS-2006-0502) Employer Comparable Contributions to Health Savings Accounts Under Section 4980G (Docket Number: HHS-OS-2008-0011) Ensuring that Department of Health and Human Services Funds Do Not Support Coercive or Discriminatory Policies or Practices In Violation of Federal Law; Proposed Rule (Docket Number: HHS_FRDOC_0001-0042) Ensuring That Department of Health and Human Services Funds Do Not Support Coercive or Discriminatory Policies or Practices in Violation of Federal Law; Final Rule (Docket Number: HHS-OPHS-2009-0001) Rescission of the Regulation Entitled Ensuring That Department of Health and Human Services Funds Do Not Support Coercive or Discriminatory Policies or Practices in Violation of Federal Law; Proposal Concept (No Bill Language) Utilizing E-Prescribing Technologies to Integrate Pharmacogenomics into Prescribing and Dispensing Practices Concept (No Bill Language) Role of Pharmacist-Provided Patient Care Services in Health Care Reform

LobbyistCovered position, as disclosed
MARCIE BOUGH Former Legislative Assistant in Senate
HARRY HAGEL —
KRISTINA E LUNNER —

Contacted: White House Office; Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Bills named: H.R. 756 (111th), H.R. 1259 (111th), H.R. 179 (111th)

Medicare/Medicaid MMM

HR616/ S511 - Access to Durable Medical Equipment Act HR203 - Medicare Fraud Prevention Act of 2009 HR27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR574 - Medicare Home Infusion Therapy Coverage Act of 2009 S266 - Medicare Prescription Drug Gap Reduction Act of 2009 (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 Sections on Medicare DMEPOS and Protected Drug Classes (Docket Number: CMS 4138IFC4) Medicare Program: Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary & Protected Classes Policies (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-0009-P) CMS Proposed Rule on Modifications to the HIPAA Electronic Transaction Standards (Docket Number: CMS0013F) HIPAA Administrative Simplification: Modifications to Medical Data Code Set Standards To Adopt ICD10CM and ICD10PCS (Docket Number: CMS2244F) Medicaid Program; Premiums and Cost Sharing (Docket Number: CMS-4131-FC;-RIN 0938-AP24) Medicare Program; Medicare Advantage and Prescription Drug Benefit Programs: Negotiated Pricing and Remaining Revisions; Final Rule; Medicare Program; Prescription Drug Benefit Program Payments to Sponsors of Retiree Prescription Drug Plans; Proposed Rule Draft 2010 Medicare Part D Call Letter

LobbyistCovered position, as disclosed
MARCIE BOUGH Former Legislative Assistant in Senate
HARRY HAGEL —
KRISTINA E LUNNER —

Contacted: White House Office; Internal Revenue Service (IRS); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Environmental Protection Agency (EPA); Food & Drug Administration (FDA)

Bills named: H.R. 616 (111th), H.R. 203 (111th), H.R. 27 (111th), H.R. 574 (111th)

Environment/Superfund ENV

(Docket Number: EPA-HQ-RCRA-2007-0932) Amendment to the Universal Waste Rule: Addition of Pharmaceuticals (Docket Number: DEA-316) Advanced Notice of Proposed Rule Making; Disposal of Controlled Substances by Persons not Registered with the Drug Enforcement Administration

LobbyistCovered position, as disclosed
MARCIE BOUGH Former Legislative Assistant in Senate
HARRY HAGEL —
KRISTINA E LUNNER —

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); SENATE; Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Internal Revenue Service (IRS); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

HR1204 - The Community Pharmacy Fairness Act of 2009 S80 - Pharmacautical Market Access Act of 2009 S525/ HR1298 - Pharmacautical Market Access and Drug Safety Act of 2009 HR163 - Prescription Drug Affordability Act (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all Pharmacy-Based Communications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting (focused on the types of communications that patientss receive at the pharmacy includes: medication guides; patients package inserts; and consumer medication information. (Docket Number: FDA2009D0001) Draft Guidance for Industry on Standards for Securing the Drug Supply ChainStandardized Numerical Identification for Prescription Drug Packages; Availability (Docket Number: FDA-2008-S-0627) Expert and Consumer Evaluation of Consumer Medication Information -- 2008 (Docket Number DoD2008HA0029; 0720AB22) Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals (Request for Information (RFI): HHS-FDA-RFI-09-002 (Special Notice)) FDA Sentinel Initiative Concept (No Language) FDA Risk Evaluation and Mitigation Strategies (REMS) for Opioid Anagesic Medications

LobbyistCovered position, as disclosed
MARCIE BOUGH Former Legislative Assistant in Senate
HARRY HAGEL —
KRISTINA E LUNNER —

Contacted: Internal Revenue Service (IRS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Food & Drug Administration (FDA); White House Office; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA)

Bills named: H.R. 1204 (111th), H.R. 163 (111th), H.R. 1298 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.